H5N1 vaccine plus AS03 adjuvant

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

InfluenzaInfluenza A Virus, H5N1 Subtype

Phase 1

Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant

CompletedNCT01578317

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2012-03-20End: 2016-01-31Updated: 2019-02-26

Phase 2

Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)

CompletedNCT01910519

National Institute of Allergy and Infectious Diseases (NIAID)Influenza A Virus, H5N1 Subtype

Start: 2013-07-31End: 2015-11-30Updated: 2019-02-12